Literature DB >> 22336289

Antibodies to Borrelia burgdorferi OspA, OspC, OspF, and C6 antigens as markers for early and late infection in dogs.

Bettina Wagner1, Heather Freer, Alicia Rollins, David Garcia-Tapia, Hollis N Erb, Christopher Earnhart, Richard Marconi, Patrick Meeus.   

Abstract

Lyme disease in the United States is caused by Borrelia burgdorferi sensu stricto, which is transmitted to mammals by infected ticks. Borrelia spirochetes differentially express immunogenic outer surface proteins (Osp). Our aim was to evaluate antibody responses to Osp antigens to aid the diagnosis of early infection and the management of Lyme disease. We analyzed antibody responses during the first 3 months after the experimental infection of dogs using a novel multiplex assay. Results were compared to those obtained with two commercial assays detecting C6 antigen. Multiplex analysis identified antibodies to OspC and C6 as early as 3 weeks postinfection (p.i.) and those to OspF by 5 weeks p.i. Antibodies to C6 and OspF increased throughout the study, while antibodies to OspC peaked between 7 and 11 weeks p.i. and declined thereafter. A short-term antibody response to OspA was observed in 3/8 experimentally infected dogs on day 21 p.i. Quant C6 enzyme-linked immunosorbent assay (ELISA) results matched multiplex results during the first 7 weeks p.i.; however, antibody levels subsequently declined by up to 29%. Immune responses then were analyzed in sera from 125 client-owned dogs and revealed high agreement between antibodies to OspF and C6 as robust markers for infection. Results from canine patient sera supported that OspC is an early infection marker and antibodies to OspC decline over time. The onset and decline of antibody responses to B. burgdorferi Osp antigens and C6 reflect their differential expression during infection. They provide valuable tools to determine the stage of infection, treatment outcomes, and vaccination status in dogs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22336289      PMCID: PMC3318275          DOI: 10.1128/CVI.05653-11

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  43 in total

Review 1.  Lyme disease.

Authors:  A C Steere
Journal:  N Engl J Med       Date:  2001-07-12       Impact factor: 91.245

2.  Demonstration of the genetic stability and temporal expression of select members of the lyme disease spirochete OspF protein family during infection in mice.

Authors:  J V McDowell; S Y Sung; G Price; R T Marconi
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

3.  Quantitative approach for the serodiagnosis of canine Lyme disease by the immunoblot procedure.

Authors:  M A Guerra; E D Walker; U Kitron
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

4.  Evaluation of whole-cell and OspC enzyme-linked immunosorbent assays for discrimination of early lyme borreliosis from OspA vaccination.

Authors:  C A Wieneke; S D Lovrich; S M Callister; D A Jobe; J A Marks; R F Schell
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

5.  Antibody response to IR6, a conserved immunodominant region of the VlsE lipoprotein, wanes rapidly after antibiotic treatment of Borrelia burgdorferi infection in experimental animals and in humans.

Authors:  M T Philipp; L C Bowers; P T Fawcett; M B Jacobs; F T Liang; A R Marques; P D Mitchell; J E Purcell; M S Ratterree; R K Straubinger
Journal:  J Infect Dis       Date:  2001-08-30       Impact factor: 5.226

6.  Reactivity of dog sera to whole-cell or recombinant antigens of Borrelia burgdorferi by ELISA and immunoblot analysis.

Authors:  Louis A Magnarelli; Steven A Levy; Jacob W Ijdo; Caiyun Wu; Steven J Padula; Erol Fikrig
Journal:  J Med Microbiol       Date:  2001-10       Impact factor: 2.472

7.  Attachment of Borrelia burgdorferi within Ixodes scapularis mediated by outer surface protein A.

Authors:  U Pal; A M de Silva; R R Montgomery; D Fish; J Anguita; J F Anderson; Y Lobet; E Fikrig
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

8.  An immunodominant conserved region within the variable domain of VlsE, the variable surface antigen of Borrelia burgdorferi.

Authors:  F T Liang; A L Alvarez; Y Gu; J M Nowling; R Ramamoorthy; M T Philipp
Journal:  J Immunol       Date:  1999-11-15       Impact factor: 5.422

9.  Status of Borrelia burgdorferi infection after antibiotic treatment and the effects of corticosteroids: An experimental study.

Authors:  R K Straubinger; A F Straubinger; B A Summers; R H Jacobson
Journal:  J Infect Dis       Date:  2000-03       Impact factor: 5.226

10.  Characterization of a Borrelia burgdorferi VlsE invariable region useful in canine Lyme disease serodiagnosis by enzyme-linked immunosorbent assay.

Authors:  F T Liang; R H Jacobson; R K Straubinger; A Grooters; M T Philipp
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

View more
  14 in total

1.  Tick-borne Diseases (Borreliosis, Anaplasmosis, Babesiosis) in German and Austrian Dogs: Status quo and Review of Distribution, Transmission, Clinical Findings, Diagnostics and Prophylaxis.

Authors:  Nikola Pantchev; Silvia Pluta; Elke Huisinga; Stephanie Nather; Miriam Scheufelen; Majda Globokar Vrhovec; Andrea Schweinitz; Herwig Hampel; Reinhard K Straubinger
Journal:  Parasitol Res       Date:  2015-08       Impact factor: 2.289

2.  Current Surveys of the Seroprevalence of Borrelia burgdorferi, Ehrlichia canis, Anaplasma phagocytophilum, Leishmania infantum, Babesia canis, Angiostrongylus vasorum and Dirofilaria immitis in Dogs in Bulgaria.

Authors:  Nikola Pantchev; Manuela Schnyder; Majda Globokar Vrhovec; Roland Schaper; Ilia Tsachev
Journal:  Parasitol Res       Date:  2015-08       Impact factor: 2.289

3.  Epitope identification from fixed-complexity random-sequence peptide microarrays.

Authors:  Josh Richer; Stephen Albert Johnston; Phillip Stafford
Journal:  Mol Cell Proteomics       Date:  2014-11-03       Impact factor: 5.911

4.  Bacterial heterogeneity is a requirement for host superinfection by the Lyme disease spirochete.

Authors:  Artem S Rogovskyy; Troy Bankhead
Journal:  Infect Immun       Date:  2014-08-11       Impact factor: 3.441

5.  Detection of antibodies to decorin-binding protein A (DbpA) and DbpB after infection of dogs with Borrelia burgdorferi by tick challenge.

Authors:  Darby G Oldenburg; Dean A Jobe; Steven D Lovrich; Rhonda L LaFleur; Douglas W White; Jennifer C Dant; Steven M Callister
Journal:  J Vet Diagn Invest       Date:  2020-03-20       Impact factor: 1.279

6.  Presence of Arp specifically contributes to joint tissue edema associated with early-onset Lyme arthritis.

Authors:  Petronella R Hove; Gary J Haldorson; Forgivemore Magunda; Troy Bankhead
Journal:  Infect Immun       Date:  2013-10-07       Impact factor: 3.441

7.  Antibody profiling of a Borreliella burgdorferi (Lyme disease) C6 antibody positive, symptomatic Rottweiler and her pups.

Authors:  A L Hatke; D R Green; K Stasiak; R T Marconi
Journal:  Vet J       Date:  2020-07-05       Impact factor: 2.688

8.  Comparison of effectiveness of cefovecin, doxycycline, and amoxicillin for the treatment of experimentally induced early Lyme borreliosis in dogs.

Authors:  Bettina Wagner; John Johnson; David Garcia-Tapia; Nicole Honsberger; Vickie King; Catherine Strietzel; John M Hardham; Thomas J Heinz; Richard T Marconi; Patrick F M Meeus
Journal:  BMC Vet Res       Date:  2015-07-25       Impact factor: 2.741

9.  Serological detection of Anaplasma phagocytophilum, Borrelia burgdorferi sensu lato and Ehrlichia canis antibodies and Dirofilaria immitis antigen in a countrywide survey in dogs in Poland.

Authors:  Friederike Krämer; Roland Schaper; Bettina Schunack; Andrzej Połozowski; Jolanta Piekarska; Aleksandra Szwedko; Robert Jodies; Dagmara Kowalska; Dörte Schüpbach; Nikola Pantchev
Journal:  Parasitol Res       Date:  2014-06-29       Impact factor: 2.289

10.  Seroprevalence of Borrelia burgdorferi in Horses Presented for Coggins Testing in Southwest Virginia and Change in Positive Test Results Approximately 1 Year Later.

Authors:  R A Funk; R S Pleasant; S G Witonsky; D S Reeder; S R Werre; D R Hodgson
Journal:  J Vet Intern Med       Date:  2016-05-23       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.